EVGN - Evogene Ltd.

NasdaqGM - NasdaqGM Real Time Price. Currency in USD
Income Statement
Balance Sheet
Cash Flow

Income Statement

All numbers in thousands
Total Revenue3,3816,54011,12914,511
Cost of Revenue2,8455,6398,2559,709
Gross Profit5369012,8744,802
Operating Expenses
Research Development16,98716,40514,44914,022
Selling General and Administrative5,4965,5856,3466,036
Non Recurring----
Total Operating Expenses25,32827,62929,05029,767
Operating Income or Loss-21,947-21,089-17,921-15,256
Income from Continuing Operations
Total Other Income/Expenses Net1,1201,533708726
Earnings Before Interest and Taxes-21,947-21,089-17,921-15,256
Interest Expense----
Income Before Tax-20,827-19,556-17,213-14,530
Income Tax Expense1136--
Minority Interest----
Net Income From Continuing Ops-20,838-19,592-17,213-14,530
Non-recurring Events
Discontinued Operations----
Extraordinary Items----
Effect Of Accounting Changes----
Other Items----
Net Income
Net Income-20,838-19,592-17,213-14,530
Preferred Stock And Other Adjustments----
Net Income Applicable To Common Shares-20,838-19,592-17,213-14,530